What should I Know Regarding Pregnancy, Nursing and Administering Atazanavir 50 Mg Oral Powder Packet to Children or the Elderly?
If you are PREGNANT
- FDB Only When Necessary: HUMAN AND ANIMAL DATA SUGGEST NO INCREASED RISK FOR DEVELOPMENTAL TOXICITY
If you are NURSING
- Absolute Contraindication: CDC DOES NOT RECOMMEND BREASTFEEDING IN HIV PATIENTS
If you are an adult over 60
Giving Atazanavir 50 Mg Oral Powder Packet to a child under 12
- management or monitoring precaution: Risk of neutropenia, hyperbilirubinemia, increased amylase, fever, nasal congestion, cough, oropharyngeal pain.
- Severe Precaution: Avoid age < 3 months old due to risk of kernicterus; risk of hyperbilirubinemia. Dosing not established.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.